97
Participants
Start Date
May 30, 2019
Primary Completion Date
April 23, 2024
Study Completion Date
April 23, 2024
0.1% atropine and 0.01% atropine
0.1% atropine loading dose for 6 months followed by 0.01% atropine for 18 months
0.01% atropine
0.01% atropine for 24 months
0.9% Sodium-chloride
Placebo for 24 months
Department of Ophthalmology, Aarhus University Hospital, Aarhus
Department of Ophthalmology, Rigshospitalet-Glostrup, Glostrup Municipality
Department of Ophthalmology, Vejle Hospital, Vejle
Aarhus University Hospital
OTHER
Vejle Hospital
OTHER
Line Kessel
OTHER